Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ASTRAZENECA PHARMA ABBOTT INDIA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 50.0 95.5 52.3% View Chart
P/BV x 18.2 22.7 80.2% View Chart
Dividend Yield % 1.2 0.3 401.1%  

Financials

 ABBOTT INDIA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
ASTRAZENECA PHARMA
Mar-23
ABBOTT INDIA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs22,4823,620 621.1%   
Low Rs16,1562,438 662.7%   
Sales per share (Unadj.) Rs2,517.0401.2 627.4%  
Earnings per share (Unadj.) Rs446.839.7 1,124.9%  
Cash flow per share (Unadj.) Rs479.746.2 1,037.9%  
Dividends per share (Unadj.) Rs325.0016.00 2,031.3%  
Avg Dividend yield %1.70.5 318.4%  
Book value per share (Unadj.) Rs1,480.5234.4 631.5%  
Shares outstanding (eoy) m21.2525.00 85.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.77.5 101.7%   
Avg P/E ratio x43.276.3 56.7%  
P/CF ratio (eoy) x40.365.5 61.5%  
Price / Book Value ratio x13.012.9 101.0%  
Dividend payout %72.740.3 180.6%   
Avg Mkt Cap Rs m410,51375,718 542.2%   
No. of employees `000NANA-   
Total wages/salary Rs m5,6362,591 217.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,48710,030 533.3%  
Other income Rs m1,543261 591.1%   
Total revenues Rs m55,03010,291 534.8%   
Gross profit Rs m12,0551,249 965.2%  
Depreciation Rs m700163 430.3%   
Interest Rs m1606 2,538.1%   
Profit before tax Rs m12,7381,341 949.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,244348 931.9%   
Profit after tax Rs m9,494993 956.2%  
Gross profit margin %22.512.5 181.0%  
Effective tax rate %25.526.0 98.1%   
Net profit margin %17.89.9 179.3%  
BALANCE SHEET DATA
Current assets Rs m30,2519,359 323.2%   
Current liabilities Rs m12,0604,844 249.0%   
Net working cap to sales %34.045.0 75.5%  
Current ratio x2.51.9 129.8%  
Inventory Days Days8749 175.6%  
Debtors Days Days239 5.5%  
Net fixed assets Rs m15,1352,061 734.2%   
Share capital Rs m21350 425.0%   
"Free" reserves Rs m31,2485,811 537.7%   
Net worth Rs m31,4605,861 536.8%   
Long term debt Rs m00-   
Total assets Rs m45,38611,421 397.4%  
Interest coverage x80.7213.9 37.7%   
Debt to equity ratio x00-  
Sales to assets ratio x1.20.9 134.2%   
Return on assets %21.38.7 243.1%  
Return on equity %30.216.9 178.1%  
Return on capital %41.023.0 178.4%  
Exports to sales %0.40-   
Imports to sales %10.837.4 28.8%   
Exports (fob) Rs m221NA-   
Imports (cif) Rs m5,7653,747 153.9%   
Fx inflow Rs m310612 50.6%   
Fx outflow Rs m5,8183,747 155.3%   
Net fx Rs m-5,508-3,135 175.7%   
CASH FLOW
From Operations Rs m8,934583 1,532.7%  
From Investments Rs m-1,477181 -815.6%  
From Financial Activity Rs m-6,387-245 2,609.2%  
Net Cashflow Rs m1,070519 206.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 8.9 5.4 164.6%  
FIIs % 0.2 2.7 6.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   72,252 29,032 248.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs ASTRAZENECA PHARMA Share Price Performance

Period Abbott India ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 0.74% 0.01% 1.18%
1-Month -5.97% -3.61% -0.75%
1-Year 24.80% 59.20% 61.82%
3-Year CAGR 21.40% 20.50% 18.16%
5-Year CAGR 29.91% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of Abbott India, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.